Welche Faktoren bestimmen die Prognose des Ovarialkarzinoms? Eine Analyse anhand eigener Daten von Primärfällen aus den Jahren 1997-2002

Seck, Katharina; Pfab, S; Schmalzried, H; Kiechle, M; Schmalfeldt, Barbara

doi:10.1055/s-0032-1318579

Geburtsh Frauenheilk

2012

DOI: 10.1055/s-0032-1318579

|View full text |Cite

Welche Faktoren bestimmen die Prognose des Ovarialkarzinoms? Eine Analyse anhand eigener Daten von Primärfällen aus den Jahren 1997-2002

Katharina Seck¹,

S Pfab²,

H Schmalzried³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ovarian cancer however is usually diagnosed at a later stage and, in addition, has a high risk of recurrence. Ovarian cancer therefore has an unfavourable prognosis [1,21,23]. Infection with human papillomavirus (HPV) is now considered a prerequisite for the development of cervical cancer [2].…”

mentioning

confidence: 99%

Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends

Waldmann¹,

Eisemann²,

Katalinic³

2013

Geburtsh Frauenheilk

View full text Add to dashboard Cite

Introduction !In addition to breast cancer, gynaecological malignancies also include cervical, endometrial and ovarian cancers. Cancer of the corpus uteri is the most common malignancy of the female genital tract, followed by ovarian and cervical cancer.In Germany, these malignancies account respectively for 5.1 % (fourth most common malignancy in women), 3.5 % (sixth most common) and 2.2 % (twelfth most common) of all newly diagnosed cancers in women. As most cervical and endometrial cancers, particularly oestrogen-dependent endometrial tumours, are diagnosed at an early Abstract ! Cervical, uterine and ovarian cancers are the most common malignancies of the female genital tract. Using current data from population-based cancer registries in Germany, we present the recent figures for the incidence, prevalence, associated mortality and survival for these cancers. In 2009, a total of 23 800 women were newly diagnosed with one of the three gynaecological cancers (cervical cancer: 20.3 %, endometrial cancer: 48.5 %, ovarian cancer: 31.2 %). This figure equals approximately one third of the number of women newly diagnosed with breast cancer in the same year. The relative 5-year survival for carcinomas of the corpus uteri is 79 % and is higher that those for cervical cancer (68 %) and ovarian cancer (40 %). Ovarian cancer in particular is often diagnosed at a later stage and has a high risk of recurrence. Due to the favourable prognosis for endometrial tumours and the unfavourable prognosis for ovarian malignancies, the incidence of various gynaecological tumours is ranked differently compared to the 5-year prevalence of these same tumours. Currently, the 5-year prevalence in Germany for patients with cervical, endometrial or ovarian cancer is estimated to be around 80 000 women. Slightly more than half of these women were diagnosed with cancer of the corpus uteri. Around 25 % of women have ovarian and 21% have cervical cancer. Zusammenfassung

show abstract

mentioning

confidence: 99%

Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends

Waldmann¹,

Eisemann²,

Katalinic³

2013

Geburtsh Frauenheilk

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Welche Faktoren bestimmen die Prognose des Ovarialkarzinoms? Eine Analyse anhand eigener Daten von Primärfällen aus den Jahren 1997-2002

Cited by 1 publication

References 0 publications

Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends

Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends

Contact Info

Product

Resources

About